These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Pharmacologic modulation of periprosthetic osteolysis. Goodman SB; Trindade M; Ma T; Genovese M; Smith RL Clin Orthop Relat Res; 2005 Jan; (430):39-45. PubMed ID: 15662302 [TBL] [Abstract][Full Text] [Related]
28. D-penicillamine-induced autoimmunity: relationship to macrophage activation. Li J; Uetrecht JP Chem Res Toxicol; 2009 Sep; 22(9):1526-33. PubMed ID: 19575532 [TBL] [Abstract][Full Text] [Related]
29. Macrophage Polarization and the Osteoimmunology of Periprosthetic Osteolysis. Goodman SB; Gibon E; Gallo J; Takagi M Curr Osteoporos Rep; 2022 Feb; 20(1):43-52. PubMed ID: 35133558 [TBL] [Abstract][Full Text] [Related]
30. New vistas on macrophage differentiation and activation. Mantovani A; Sica A; Locati M Eur J Immunol; 2007 Jan; 37(1):14-6. PubMed ID: 17183610 [TBL] [Abstract][Full Text] [Related]
31. Effect of oral erythromycin therapy in patients with aseptic loosening of joint prostheses. Ren W; Blasier R; Peng X; Shi T; Wooley PH; Markel D Bone; 2009 Apr; 44(4):671-7. PubMed ID: 19154802 [TBL] [Abstract][Full Text] [Related]
32. Wear particles of total joint replacements and their role in periprosthetic osteolysis. Jasty M; Smith E Curr Opin Rheumatol; 1992 Apr; 4(2):204-9. PubMed ID: 1581149 [TBL] [Abstract][Full Text] [Related]
33. Macrophage polarization in tumour progression. Sica A; Larghi P; Mancino A; Rubino L; Porta C; Totaro MG; Rimoldi M; Biswas SK; Allavena P; Mantovani A Semin Cancer Biol; 2008 Oct; 18(5):349-55. PubMed ID: 18467122 [TBL] [Abstract][Full Text] [Related]
35. The role of macrophages in inflammatory bowel diseases. Heinsbroek SE; Gordon S Expert Rev Mol Med; 2009 May; 11():e14. PubMed ID: 19439108 [TBL] [Abstract][Full Text] [Related]
36. Extrinsic and intrinsic pathways of apoptosis in aseptic loosening after total hip replacement. Landgraeber S; von Knoch M; Löer F; Wegner A; Tsokos M; Hussmann B; Totsch M Biomaterials; 2008; 29(24-25):3444-50. PubMed ID: 18490052 [TBL] [Abstract][Full Text] [Related]
37. Modulation of osteoclast function in bone by the immune system. Quinn JM; Saleh H Mol Cell Endocrinol; 2009 Oct; 310(1-2):40-51. PubMed ID: 19056462 [TBL] [Abstract][Full Text] [Related]
38. Is oral vitamin D a risk factor for prosthetic loosening? Peersman G; Bellemans J; Richart T Acta Orthop Belg; 2009 Feb; 75(1):2-7. PubMed ID: 19358390 [TBL] [Abstract][Full Text] [Related]
39. A review on macrophage responses to biomaterials. Xia Z; Triffitt JT Biomed Mater; 2006 Mar; 1(1):R1-9. PubMed ID: 18458376 [TBL] [Abstract][Full Text] [Related]